Otofarma SpA (MIL:OTO) EV-to-EBITDA: (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:OTO Otofarma SpA MIL:OTO
16 GF Score
Price €2.62
! 1 Warning Sign
View Full Analysis

What is Otofarma SpA EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Otofarma SpA's enterprise value is €15.95 Mil. Otofarma SpA does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Dec. 2024. Therefore, GuruFocus does not calculate Otofarma SpA's EV-to-EBITDA at this moment.

The historical rank and industry rank for Otofarma SpA's EV-to-EBITDA or its related term are showing as below:

MIL:OTO' s EV-to-EBITDA Range Over the Past 10 Years
Min: 0   Med: 0   Max: 7.28
Current: 6.92

During the past 2 years, the highest EV-to-EBITDA of Otofarma SpA was 7.28. The lowest was 0.00. And the median was 0.00.

MIL:OTO's EV-to-EBITDA is ranked better than
81.57% of 510 companies
in the Medical Devices & Instruments industry
Industry Median: 13.93 vs MIL:OTO: 6.92

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2026-07-22), Otofarma SpA's stock price is €2.62. Otofarma SpA does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024. Therefore, GuruFocus does not calculate Otofarma SpA's PE Ratio (TTM) at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).

Otofarma SpA  (MIL:OTO) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Otofarma SpA's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2.62/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Otofarma SpA EV-to-EBITDA Related Terms

Otofarma SpA EV-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Otofarma SpA's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otofarma SpA EV-to-EBITDA Chart

Otofarma SpA Annual Data
Trend Dec23 Dec24
EV-to-EBITDA
0.00 0.00

Otofarma SpA Semi-Annual Data
Dec23 Dec24
EV-to-EBITDA 0.00 0.00

MIL:OTO vs ABT, SYK, MDT: EV-to-EBITDA Comparison

For the Medical Devices subindustry, Otofarma SpA's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Otofarma SpA EV-to-EBITDA vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Otofarma SpA's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Otofarma SpA's EV-to-EBITDA falls into.


MIL:OTO
16GF Score
Otofarma SpA MIL:OTO
EV-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Otofarma SpA EV-to-EBITDA Calculation

Otofarma SpA's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=15.951/
=

Otofarma SpA Business Description

Address Ripuaria Way, 50k, Marina di Varcaturo, Naples, ITA, 80014
Otofarma SpA is engaged in the construction and production of hearing aids, is constantly growing in the audiological field to provide adequate responses to every type of hearing aid need to its customers who require the possible personalized application of custom-made hearing aids. It provides otoacoustic medical devices and TELEMEDICINE services exclusively in affiliated pharmacies, possessing a portfolio of Instrumental IT patents.
16GF Score

Get the complete analysis for MIL:OTO

EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.62
Price